![Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma? | Semantic Scholar Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8107a4b51fa37611733ccc8319ee985101cb613d/4-Table2-1.png)
Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma? | Semantic Scholar
![Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/bcf6382a-a372-4f23-8b06-847ee9912229/gr1_lrg.gif)
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Critical Care Alerts: Effect of Ultra-Short-Acting Beta-blockers on Mortality in Patients with Persistent Tachycardia Despite Initial Fluid Resuscitation: A Systematic Review and Meta-Analysis EMRA Critical Care Alerts: Effect of Ultra-Short-Acting Beta-blockers on Mortality in Patients with Persistent Tachycardia Despite Initial Fluid Resuscitation: A Systematic Review and Meta-Analysis EMRA](https://www.emra.org/siteassets/emresident/images/series/critical-care-alert/cca-beta-blockers.png?w=600)
Critical Care Alerts: Effect of Ultra-Short-Acting Beta-blockers on Mortality in Patients with Persistent Tachycardia Despite Initial Fluid Resuscitation: A Systematic Review and Meta-Analysis EMRA
![Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease | JACC: Heart Failure Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease | JACC: Heart Failure](https://www.jacc.org/cms/asset/3e0aa69b-69b7-4403-80f5-152477a9f111/fx1.jpg)
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease | JACC: Heart Failure
![BETA ADRENOCEPTOR BLOCKERS. OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL. - ppt download BETA ADRENOCEPTOR BLOCKERS. OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL. - ppt download](https://images.slideplayer.com/28/9359789/slides/slide_6.jpg)